Dror Harats, MD

Prof. Harats founded VBL in 2000 based on more than 20 years of both research in the field of medicine and biotechnology, as well as a strong background in management of early- to mid-stage biotechnology companies. He is also a professional and experienced consultant specializing in Biotechnology/Pharmaceutical healthcare companies. A professor of medicine in the department of internal medicine and the department of human molecular genetics and biochemistry at the Sackler Faculty of Medicine, Tel-Aviv University, Prof. Harats is the President of the Bert Strassburger Lipid Center, chair the division of R&D and the Chairman of the IRB committee of the Sheba Medical Center, supervising about 2000 clinical trials annually. Prof. Harats published more than 180 peer-reviewed research papers and chapters in books, his publications rewarded him with numerous prizes and grants.